Inherited retinal diseases: linking genes, disease-causing variants, and relevant therapeutic modalities

N Schneider, Y Sundaresan, P Gopalakrishnan… - Progress in retinal and …, 2022 - Elsevier
Inherited retinal diseases (IRDs) are a clinically complex and heterogenous group of visual
impairment phenotypes caused by pathogenic variants in at least 277 nuclear and …

RNA splicing and disease: animal models to therapies

M Montes, BL Sanford, DF Comiskey, DS Chandler - Trends in Genetics, 2019 - cell.com
Alternative splicing of pre-mRNA increases genetic diversity, and recent studies estimate
that most human multiexon genes are alternatively spliced. If this process is not highly …

Astrocytes close the mouse critical period for visual plasticity

J Ribot, R Breton, CF Calvo, J Moulard, P Ezan… - Science, 2021 - science.org
Brain postnatal development is characterized by critical periods of experience-dependent
remodeling of neuronal circuits. Failure to end these periods results in neurodevelopmental …

Impairment of glycolysis-derived l-serine production in astrocytes contributes to cognitive deficits in Alzheimer's disease

J Le Douce, M Maugard, J Veran, M Matos, P Jégo… - Cell metabolism, 2020 - cell.com
Alteration of brain aerobic glycolysis is often observed early in the course of Alzheimer's
disease (AD). Whether and how such metabolic dysregulation contributes to both synaptic …

Physiological synaptic activity and recognition memory require astroglial glutamine

G Cheung, D Bataveljic, J Visser, N Kumar… - Nature …, 2022 - nature.com
Presynaptic glutamate replenishment is fundamental to brain function. In high activity
regimes, such as epileptic episodes, this process is thought to rely on the glutamate …

Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model

R Fol, J Braudeau, S Ludewig, T Abel, SW Weyer… - Acta …, 2016 - Springer
Alzheimer's disease (AD) is characterized by synaptic failure, dendritic and axonal atrophy,
neuronal death and progressive loss of cognitive functions. It is commonly assumed that …

Nanotechnology-based strategies to overcome current barriers in gene delivery

S Mirón-Barroso, EB Domènech… - International journal of …, 2021 - mdpi.com
Nanomaterials are currently being developed for the specific cell/tissue/organ delivery of
genetic material. Nanomaterials are considered as non-viral vectors for gene therapy use …

The self-inactivating KamiCas9 system for the editing of CNS disease genes

N Merienne, G Vachey, L de Longprez, C Meunier… - Cell reports, 2017 - cell.com
Neurodegenerative disorders are a major public health problem because of the high
frequency of these diseases. Genome editing with the CRISPR/Cas9 system is making it …

The pathogenicity of splicing defects: mechanistic insights into pre‐mRNA processing inform novel therapeutic approaches

E Daguenet, G Dujardin, J Valcárcel - EMBO reports, 2015 - embopress.org
Removal of introns from pre‐mRNA precursors (pre‐mRNA splicing) is a necessary step for
the expression of most genes in multicellular organisms, and alternative patterns of intron …

Molecular therapies for inherited retinal diseases—current standing, opportunities and challenges

I Vázquez-Domínguez, A Garanto, RWJ Collin - Genes, 2019 - mdpi.com
Inherited retinal diseases (IRDs) are both genetically and clinically highly heterogeneous
and have long been considered incurable. Following the successful development of a gene …